The global Candidiasis Market is estimated to be valued at US$ 984.80 Mn in 2023 and is expected to exhibit a CAGR of 3.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Candidiasis refers to infections caused by yeasts of the genus Candida, such as C. albicans. The infections can range from superficial, such as oral thrush and ... Read more
Candidiasis, commonly known as thrush, is a fungal infection caused by yeast species Candida, which affects the mucous membranes of the mouth, throat, and genitals. Candidiasis infections are generally treated with antifungal medicines such as fluconazole, itraconazole, and nystatin. The increasing prevalence of candida infections globally due to rising virulence of candida yeasts and growing immunocompromised population is expected to drive the growth of the candidiasis market.
